This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
34


nanotimes


Companies Facts


K Power Plastic®


onarka Technologies, Inc., an innovator in de- velopment and commercialization of Konarka , lightweight, flexible, semi-transparent


solar panels, announced that Kevin Debasitis has joined the company as new director of business de- velopment.


Moreover, Konarka has settled a patent lawsuit against Plextronics. The lawsuit was settled on grounds mutually satisfactory to each party.


http://www.konarka.com W


ith the new Leica SR GSD from Leica Micro- systems, scientists can now achieve resolu-


tions far below the limit of diffraction that have never been attained before in widefield fluorescence mi- croscopy. The system is capable of resolving details as small as 20nm. This enables research of structures of single proteins and other biomolecules in cells and observation of molecular processes to gain new insights into fundamental processes of life.


http://www.leica-microsystems.com L iquidmetal® Technologies Inc. (OTCBB: LQMT) announced Scott Gillis has been elected to serve


on the Board of Directors of Liquidmetal Technolo- gies. Mr. Gillis is currently a Senior Vice President, Finance, of SunAmerica Financial Group, speciali- zing in retirement savings and investment product services.


http://www.liquidmetal.com L


una Innovations Incorporated (NASDAQ: LUNA) announced its financial results for the second


quarter and six months ended June 30, 2011. Total revenues increased by 7%, from $9.0 million in the second quarter of 2010 to $9.6 million in the second quarter of 2011. As compared to the same quarter last year, product and license revenue increased by 38%, from $2.9 million in the second quarter of 2010 to $4.0 million in the second quarter of 2011, while total revenue increased by 7%, from $9.0 million in the second quarter of 2010 to $9.6 million in the second quarter of 2011. Gross profit increased from $3.3 million for the second quarter of 2010 to $3.7 million for the second quarter of 2011. The company reported a net loss attributable to common stockholders of $0.3 million, or $0.02 per common share for the second quarter of 2011, as compared to a net loss attributable to common stockholders of $0.7 million, or $0.05 per common share for the second quarter of 2010.


htp://www.lunainnovations.com M


agnisense, a developer of next generation bioassays for human and animal diagnostics,


food safety and environmental protection, has com- pleted a new round of financing raising a total of EUR1m from its current shareholders, who confirmed their faith in the MIAtek®


technology as well as their


strong commitment towards Magnisense. This new round of financing provides the company with the resources to sustain its program through 2012.


Magnisense was incorporated in 2004 and has been based in Paris and San Francisco since 2007 and 2009, respectively. The company develops and


11-08 :: August 2011


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103